A fatal case of Behçet's disease with rare complications

Saudi Medical Journal

Volumn 27, Issue 11, 2006, Pages 1754-1757

  Sahin, Mehmet ^a   Arslan, Cagatay ^b   Tunc, Sevket E ^a   Yavuz, Turhan ^b   Goksu, Sema S ^b  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; FUROSEMIDE; HOMOCYSTEINE; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; PREDNISOLONE; WARFARIN; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; BEHCET DISEASE; CASE REPORT; CREATININE BLOOD LEVEL; DEATH; DEEP VEIN THROMBOSIS; DISEASE DURATION; DOPPLER ECHOGRAPHY; DRUG DOSE REDUCTION; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; DYSPNEA; FACE EDEMA; FATALITY; GENITAL ULCER; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HUMAN; IMAGE ANALYSIS; INFERIOR CAVA VEIN; INTERNAL JUGULAR VEIN; KIDNEY FAILURE; KIDNEY VEIN; LUNG DISEASE; MALE; METABOLIC ACIDOSIS; MOUTH ULCER; PATIENT COMPLIANCE; PERICARDIAL EFFUSION; PUSTULE; RARE DISEASE; RECURRENT DISEASE; THROMBOPHLEBITIS; TRANSTHORACIC ECHOCARDIOGRAPHY; VEIN THROMBOSIS; BLOOD; ECHOGRAPHY; JUGULAR VEIN; MORTALITY; RENAL REPLACEMENT THERAPY;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; BEHCET SYNDROME; CREATININE; CYCLOPHOSPHAMIDE; GLUCOCORTICOIDS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JUGULAR VEINS; MALE; PREDNISOLONE; RENAL DIALYSIS; RENAL VEINS; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 35948929230     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Kaklamani VG, Vaiopoulus G, Kaklamanis PG. Behçet's disease. Semin Arthritis Rheum 1998; 27: 197-217.
2. Kural-Seyahi E, Fresjo I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behçet Syndrome: A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 2003; 82: 60-76.
3. Koc Y, Gullu G, Akpek G, Akpolat T, Kansu E, Kiraz S, et al. Vascular involvement in Behçet's disease. J Rheumatol 1992; 19: 402-410.
4. Kuzu MA, Ozaslan C, Koksoy C, Gurler A, Tuzuner A. Vascular involvement in Behçet's disease: 8-year audit. World J Surg 1994; 18: 948-954.
5. Bismuth E, Hadengue A, Hammel P, Benhamou JP. Hepatic vein thrombosis in Behçet's disease. Hepatology 1990; 11: 969-974.
6. Gurgum C, Ercan E, Ceyhan C, Yavuzgil O, Zoghi M, Aksu K, et al. Cardiovascular involvement in Behçet's disease. Jpn Heart J 2002; 43: 389-398.
7. Vaiopoulos G, Stamatelos G, Aessopos A, Michael S, Christopoulos G, Aklamanis PH, et al. Asymptomatic pericarditis in Adamantiadis-Behcet's disease. Clin Exp Rheumatol 1995; 13: 649-651.
8. Akpolat T, Diri B, Oguz Y, Yilmaz E, Dilek M, et al. Behçet's disease and renal failure. Nephrol Dial Transplant 2003; 18: 888-891.
9. Estrach C, Mpofu S, Moots RJ. Behçet's syndrome response to infliximab after failure of etanercept. Rheumatology 2002; 41: 1213-1214.
10. Calguneri M, Ozturk MA, Ertenli I, Kiraz S, Apras S, Ozbalkan Z, et al. Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: An open study. Ann Rheum Dis 2003; 62: 492-493.